Boditech Med바디텍메드
206640 · KOSDAQ · ₩206640 · 바디텍메드
₩8,560▲ ₩60 (0.71%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 58.7% | 59.2% | 59.2% | 60.3% | 60.0% | 62.4% |
| Operating margin | 15.3% | 17.9% | 18.9% | 21.2% | 20.9% | 32.9% |
| Net margin | 14.8% | 14.6% | 19.7% | 19.9% | 21.4% | 30.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +7.8% | +17.3% | +2.9% | +13.7% | −25.1% | — |
| Operating income growth | −7.7% | +10.7% | −8.2% | +15.4% | −52.5% | — |
| Net income growth | +9.7% | −13.1% | +2.1% | +5.5% | −46.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 10.8% | 10.7% | 13.7% | 15.2% | 16.1% | 31.4% |
| Return on assets | 9.0% | 8.9% | 11.3% | 12.6% | 13.0% | 24.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 16.1% | 15.3% | 14.2% | 15.4% | 11.9% | 19.2% |
| Net debt to equity | −8.5% | −1.7% | −17.5% | −16.8% | −10.9% | −20.9% |
| Current ratio | 546.1% | 523.8% | 496.0% | 508.6% | 727.7% | 483.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Boditech Med / 바디텍메드 / 206640 / KRX:206640
Source: KRX statistical information